PHAT- Phathom Pharmaceuticals, Inc.

Name: Phathom Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Phathom Pharmaceuticals, Inc. (PHAT) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 51 sells. PHAT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Basta Steven L	373.3K	$3.99M	-
CFO	Narula Sanjeev	226.7K	$2.42M	-
Other	Cook Anne Marie	90.2K	$964.2K	-
Other	Breedlove Robert Charles	47.8K	$511.5K	-
Dir	Parikh Asit	10.5K	$112.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 22, 2021	Curran Terrie68	President And Chief Executive	Sale+OE	11,513	$43.32	$498,750.86	-91.0%	-18.9%	-66.2%
Mar 12, 2021	Socks David A91	Director	Sell	55,000	$47.58	$2,617,090.16	-0.6%	-22.1%	-69.5%
Mar 11, 2021	Ra Capital Management, L.P.53	10% Owner	Sell	710,000	$43.75	$31,062,500.00	-18.6%	-22.7%	-69.5%
Mar 2, 2021	Nabulsi Azmi74	Chief Operating Officer	Sell	14,500	$45.88	$665,290.08	-0.3%	-	-
Feb 23, 2021	Socks David A91	Director	Sell	70,000	$46.49	$3,254,612.12	-0.5%	-	-
Feb 2, 2021	Nabulsi Azmi74	Chief Operating Officer	Sell	14,500	$39.89	$578,440.68	-0.6%	-	-
Jan 12, 2021	Socks David A91	Director	Sell	40,000	$35.70	$1,428,037.94	-0.9%	-	-
Dec 17, 2020	Socks David A91	Director	Sell	79,658	$43.42	$3,458,895.77	-0.7%	-	-
Dec 2, 2020	Nabulsi Azmi74	Chief Operating Officer	Sell	14,500	$44.74	$648,688.04	-0.4%	-	-
Nov 11, 2020	Socks David A91	Director	Sell	30,342	$41.30	$1,253,198.14	-0.2%	-	-

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC